These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II. Becker DL; Fredenburgh JC; Stafford AR; Weitz JI J Biol Chem; 1999 Mar; 274(10):6226-33. PubMed ID: 10037709 [TBL] [Abstract][Full Text] [Related]
5. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches. Bhunia SS; Roy KK; Saxena AK J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine. Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of serine proteinases from blood coagulation cascade - view on current developments. Danalev D Mini Rev Med Chem; 2012 Jul; 12(8):721-30. PubMed ID: 22512557 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis. Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on the in vitro effectiveness of antithrombotic agents. Pâques EP; Römisch J Thromb Res; 1991 Oct; 64(1):11-21. PubMed ID: 1776137 [TBL] [Abstract][Full Text] [Related]
10. The Research Progress of Direct Thrombin Inhibitors. Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402 [TBL] [Abstract][Full Text] [Related]
11. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the activities of thrombin and plasmin by cholesterol sulfate as a physiological inhibitor in human plasma. Iwamori M; Iwamori Y; Ito N J Biochem; 1999 Mar; 125(3):594-601. PubMed ID: 10050049 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin. Callas DD; Hoppensteadt D; Fareed J Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140 [TBL] [Abstract][Full Text] [Related]
15. Azetidin-2-one derivatives as inhibitors of thrombin. Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985 [TBL] [Abstract][Full Text] [Related]
16. Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa. Olson ST; Swanson R; Petitou M Blood; 2012 Mar; 119(10):2187-95. PubMed ID: 22144183 [TBL] [Abstract][Full Text] [Related]
17. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition. Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357 [TBL] [Abstract][Full Text] [Related]
18. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency. Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707 [TBL] [Abstract][Full Text] [Related]